ArticleClinical medicine insights. Circulatory, respiratory and pulmonary medicine2022

Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19.

Rosie S Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.